L

Lantern Pharma
D

LTRN

3.07000
USD
-0.07
(-2.23%)
Market Closed
Volume
8,051
EPS
-2
Div Yield
-
P/E
-2
Market Cap
33,109,106
News

Title: Lantern Pharma

Sector: Healthcare
Industry: Biotechnology
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.